Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3132
-0.0048 (-1.51%)
At close: Jun 5, 2026, 4:00 PM EDT
0.3061
-0.0071 (-2.27%)
After-hours: Jun 5, 2026, 7:59 PM EDT
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $49.99 million as of June 5, 2026. Its market cap has decreased by -85.96% in one year.
Market Cap
49.99M
Enterprise Value
13.77M
1-Year Change
-85.96%
Ranking
Category
Stock Price
$0.31
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $49.99M, a decrease of -59.95%. That is a compound annual growth rate of -12.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 49.99M | -24.61% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 55.21M |
| Immutep | 52.61M |
| aTyr Pharma | 50.30M |
| Metagenomi Therapeutics | 50.07M |
| Hyperion DeFi | 49.72M |
| Xilio Therapeutics | 49.72M |
| Estrella Immunopharma | 49.49M |
| Lantern Pharma | 48.17M |